Science Speaks is at IDWeek in San Diego, California this week, bringing live coverage of sessions on HIV, TB, Ebola and more. SAN DIEGO, Calif – Despite steady progress made against the HIV pandemic over the past decade, only one third of people living with HIV are on antiretroviral therapy, leaving over 23 million people in need […]
Science Speaks is at IDWeek in San Diego, California this week, bringing live coverage of sessions on HIV, TB, Ebola and more. SAN DIEGO, Calif. – After the HPTN 052 trial settled the question of whether early HIV treatment prevents transmission of the virus, the START trial settled the question of the value of treatment for individual health, Dr. Myron Cohen […]
HIV
By Richard Ngethe, MBA, Data.FI As a data clerk in Kenya in 2005, my challenge was to work at rural hospitals digitizing client-level longitudinal data for […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]